비교리스트

 카트 문의
시장보고서
상품코드
1617388

세계의 의료용 엘라스토머 시장 : 유형별, 용도별, 최종 이용 산업별, 지역별 - 예측(-2029년)

Medical Elastomer Market by Type (Thermoset Elastomers; Thermoplastic Elastomers), Applications (Medical Tubing; Catheters; Syringes; Gloves; Medical & Infusion Bags and Implants), End-use Industry & Region - Global Forecast to 2029
발행일: | 리서치사: MarketsandMarkets | 페이지 정보: 영문 333 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 의료용 엘라스토머 시장 규모는 2024년 95억 7,000만 달러에서 2029년까지 연평균 8.3% 성장해 142억 7,000만 달러에 달할 것으로 예상됩니다.

의료기기에 대한 수요 증가는 전 세계적으로 의료용 엘라스토머에 대한 수요를 촉진하고 있습니다. 이는 주사기, 밸브, 튜브와 같은 일회용 의료기기 및 인공 심장 판막, 인공 관절과 같은 중요한 임플란트에서 엘라스토머의 사용 증가에 따른 결과입니다. 이 소재들은 내구성, 생체적합성, 유연성을 갖추고 있어 의료용 튜브, 가방, 장갑 등 다양한 의료용도에 적합합니다. 개발도상국의 의료비 증가와 기술 발전은 이러한 중요한 제품에 대한 수요 증가에 더욱 박차를 가할 것이며, 전 세계적으로 증가하는 의료 수요를 충족시키는 데 더욱 필수적인 요소가 될 것으로 예상됩니다. 또한, 신흥 경제국의 인구 증가와 만성 질환의 유행은 의료용 엘라스토머에 대한 수요를 창출하고 있습니다.

조사 범위
조사 대상년도 2020-2029년
기준 연도 2023년
예측 기간 2024-2029년
단위 킬로톤, 백만 달러
부문 유형, 기술, 용도, 최종 사용 산업
대상 지역 아시아태평양, 북미, 유럽, 중동/아프리카, 남미

"용도별로는 임플란트가 예측 기간 동안 의료용 엘라스토머 시장에서 금액 기준으로 가장 빠르게 성장하는 용도가 될 것입니다."

임플란트는 의료 시술에서 생체 적합성, 내구성, 유연성을 갖춘 재료에 대한 수요가 증가함에 따라 의료용 엘라스토머 응용 분야에서 가장 빠르게 성장하고 있는 분야입니다. 만성 질환의 유행과 고령화로 인해 정형외과, 치과 및 연조직 임플란트에서 우수한 성능을 제공하는 내구성이 뛰어난 의료용 엘라스토머 임플란트에 대한 수요가 증가하고 있습니다. 유연성, 편안함, 낮은 합병증은 임플란트의 매력을 더욱 높이고 있습니다. 또한, 엘라스토머는 복잡한 형태로 성형할 수 있고 생체 적합성이 뛰어나 향후 맞춤형 임플란트의 활용이 예상되어 의료용 엘라스토머에 대한 수요가 더욱 증가할 것으로 예상됩니다.

"최종 사용 산업별로는 병원 및 클리닉이 예측 기간 동안 의료용 엘라스토머 시장에서 금액 기준으로 가장 큰 점유율을 차지할 것으로 예상됩니다."

병원 및 클리닉은 엘라스토머 소재에 대한 의존도가 높기 때문에 의료용 엘라스토머 시장에서 가장 큰 점유율을 차지하고 있습니다. 이들 의료기관은 환자의 적절한 치료와 관리를 위해 카테터, 의료용 튜브, 씰, 개스킷, 수술용 장갑, 임플란트 등 다양한 의료용 엘라스토머 기반 제품을 필요로 하고 있습니다. 한편, 노인 인구 증가와 당뇨병, 심혈관 질환, 호흡기 질환 등 만성 질환의 유행으로 인해 의료 서비스의 필요성이 증가함에 따라 이러한 의료기기에 대한 수요가 더욱 증가하고 있습니다. 의료용 엘라스토머는 생체적합성, 뛰어난 유연성, 내구성, 내화학성 등의 특성으로 인해 병원 및 진료소에서 다양한 용도로 높은 기능성을 발휘합니다. 이러한 요인에 더해 FDA와 같은 의료 당국의 엄격한 규제 요건으로 인해 병원 및 클리닉은 고품질 엘라스토머 기반 제품을 채택하고 있습니다. 이러한 요인과 더불어, 강력한 의료 수요와 규제 요건 준수, 첨단 및 신뢰성 높은 의료기기로의 이동으로 인해 의료용 엘라스토머 시장에서 병원 및 클리닉은 산업별 시장 점유율이 가장 큰 시장으로 부상했습니다.

"지역별로는 아시아태평양이 의료용 엘라스토머 시장에서 금액 기준으로 두 번째로 큰 시장 규모를 차지하고 있습니다."

아시아태평양이 의료용 엘라스토머 시장에서 두 번째로 큰 시장 규모를 차지하고 있는 것은 경제 발전, 급속한 인구 증가, 우수한 의료 부문, 의료기기 수요 증가 등 다양한 요인에 기인합니다. 중국, 인도 등 신흥 경제국의 의료 인프라 투자 증가로 의료용 튜브, 임플란트, 진단기기 등 의료기기에 고품질 의료용 엘라스토머를 채택하려는 수요가 증가하고 있습니다. 이 지역은 인구가 많고 고령화가 진행되면서 만성 질환의 유병률이 증가하고 있어 이러한 수요를 더욱 촉진하고 있습니다. 따라서 아시아태평양은 의료 접근성 개선에 주력하는 의료 시설 조직과 관련된 성장 제품으로 세계 의료용 엘라스토머 시장의 주요 지역으로 자리매김하고 있습니다.

세계 의료용 엘라스토머 시장에 대해 조사 분석했으며, 주요 촉진 및 억제요인, 경쟁 구도, 향후 동향 등의 정보를 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

  • 의료용 엘라스토머 시장 기업에 있어서 매력적인 기회
  • 의료용 엘라스토머 시장 : 유형별(2024년·2029년)
  • 의료용 엘라스토머 시장 : 용도별(2024년·2029년)
  • 의료용 엘라스토머 시장 : 최종 이용 산업별(2024년·2029년)
  • 의료용 엘라스토머 시장 : 주요 국가별

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 기회
    • 과제
  • Porter의 Five Forces 분석
  • 주요 이해관계자와 구입 기준
  • 거시경제 전망
  • AI/생성형 AI의 영향
  • 밸류체인 분석
  • 생태계 분석
  • 사례 연구 분석
  • 규제 상황
    • 환경 규제
    • 북미
    • 아시아태평양
    • 유럽
    • 규제기관, 정부기관, 기타 조직
  • 기술 분석
    • 주요 기술
    • 보완 기술
    • 인접 기술
  • 고객의 비즈니스에 영향을 미치는 동향/혼란
  • 무역 분석
    • 수입 시나리오(HS코드 391000)
    • 수출 시나리오(HS코드 391000)
    • 수입 시나리오(HS코드 400270)
    • 수출 시나리오(HS코드 400270)
  • 주요 컨퍼런스 및 이벤트(2024년-2025년)
  • 가격 분석
    • 의료용 엘라스토머 평균 판매 가격 동향 : 지역별
    • 의료용 엘라스토머 평균 판매 가격 동향 : 용도별
    • 의료용 엘라스토머 평균 판매 가격 동향 : 최종 이용 산업별
  • 투자와 자금조달 시나리오
  • 특허 분석
    • 서론
    • 특허 법적 지위
    • 관할 분석
  • 잠재 고객 리스트

제6장 의료용 엘라스토머 시장 : 기술별

  • 서론
  • 압출 성형
  • 사출 성형
  • 압축 성형
  • 기타 기술

제7장 의료용 엘라스토머 시장 : 최종 이용 산업별

  • 서론
  • 병원 및 진료소
  • 제약
  • 의료기기 제조
  • 기타 최종 이용 산업

제8장 의료용 엘라스토머 시장 : 용도별

  • 서론
  • 의료용 튜브
  • 카테터
  • 장갑
  • 주사기
    • 프리필드 시린지
    • 비프리필드 시린지
    • 바이알
  • 의료 및 수액백
  • 임플란트
  • 기타 용도

제9장 의료용 엘라스토머 시장 : 유형별

  • 서론
  • 열경화성 엘라스토머
    • 실리콘
    • 에틸렌 프로필렌 디엔 모노머
    • 기타 열경화성 엘라스토머
  • 열가소성 엘라스토머
    • 열가소성 폴리우레탄
    • 스티렌계 블록 공중합체
    • 기타 열가소성 엘라스토머

제10장 의료용 엘라스토머 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 인도네시아
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 남미
    • 브라질
    • 아르헨티나
    • 기타 남미

제11장 경쟁 구도

  • 개요
  • 주요 시장 진출기업의 전략/강점(2019년-2024년)
  • 매출 분석(2021년-2023년)
  • 시장 점유율 분석(2023년)
    • 북미 시장 점유율 분석 : 용도별(2023년)
    • 유럽 시장 점유율 분석 : 용도별(2023년)
    • 아시아태평양 시장 점유율 분석 : 용도별(2023년)
    • DOW
    • EXXON MOBIL CORPORATION
    • CELANESE CORPORATION
    • BASF
    • WACKER CHEMIE AG
  • 기업 평가와 재무 지표
  • 브랜드/제품 비교
    • 의료용 엘라스토머 시장 : 브랜드/제품 비교 분석
    • ELASTOLLAN
    • ENGAGE 8480K HEALTH+
    • HYTREL
    • ECDEL
  • 기업 평가 매트릭스 : 주요 기업(2023년)
  • 기업 평가 매트릭스 : 스타트업/중소기업(2023년)
  • 경쟁 시나리오

제12장 기업 개요

  • 주요 기업
    • DOW
    • EXXON MOBIL CORPORATION
    • CELANESE CORPORATION
    • BASF
    • WACKER CHEMIE AG
    • EASTMAN CHEMICAL COMPANY
    • SYENSQO
    • KURARAY CO., LTD
    • MITSUBISHI CHEMICAL GROUP CORPORATION
    • MOMENTIVE PERFORMANCE MATERIALS
    • ENVALIOR
    • ZEON CORPORATION
    • THE LUBRIZOL CORPORATION
  • 기타 기업
    • KRATON CORPORATION
    • FOSTER CORPORATION
    • BIOMERICS
    • RTP COMPANY
    • ROMAR ENGINEERING
    • THE RUBBER GROUP
    • KENT ELASTOMER PRODUCTS
    • RAUMEDIC AG
    • THE HYGENIC COMPANY, LLC
    • HEXAPOL AB
    • TEKNI-PLEX, INC
    • TRINSEO
    • TRELLEBORG AB
    • SAINT-GOBAIN

제13장 부록

LSH 25.01.03

The medical elastomer market is projected to reach USD 14.27 billion by 2029 from USD 9.57 billion in 2024, at a CAGR of 8.3%. Growing demand for medical devices is fueling the demand for medical elastomers worldwide. This is a result of the increased use in disposable medical equipment, such as syringes, valves, tubing, and critical implants; artificial heart valves and artificial joints. These materials are versatile, offering durability, biocompatibility, and flexibility, making them suitable in a wide range of medical applications, such as medical tubes, bags, and gloves. The growing healthcare costs in developing economies coupled with technology advancements will further fuel the increasing demand for these critical commodities, rendering them even more indispensable to meet growing healthcare needs across the world. Additionally, the expanding population in emerging economies along with the rising prevalence of chronic diseases is creating a demand for medical elastomers.

Scope of the Report
Years Considered for the Study2020-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredKiloton; Value (USD Million)
SegmentsType, Technology, Application, and End-use Industry
Regions coveredAsia Pacific, North America, Europe, Middle East & Africa, and South America

"Based on application, implants are the fastest growing application in medical elastomer market during the forecast period, in terms of value."

Implants are the fastest growing application of medical elastomers due to increasing demand for biocompatible, durable and flexible materials in medical procedures. The rising prevalence of chronic diseases and aging populations are driving the need of durable implants in medical elastomers, as it provides superior orthopedic, dental, and soft tissue implant performance. Flexibility and comfort with least complications further make them appealing. Moreover, the ability of elastomers to be molded into complex shapes and the excellent biocompatibility enhances the future applications of customized implants, thereby further fueling the demand for medical elastomers.

"Based on end-use industry, hospitals & clinics account the largest share in medical elastomer market during the forecast period, in terms of value."

Hospitals and clinics account for the largest share in the medical elastomer market due to their heavy dependence on medical devices and equipment that utilize elastomer materials. These institutions need a wide range of products based on medical elastomers such as catheters, medical tubing, seals, gaskets, surgical gloves, and implants, in order to ensure appropriate patient care and treatment. However, the growing need for healthcare services due to growing ageing population and rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders further boosts the demand for these medical devices. The properties of medical elastomers such as biocompatibility and excellent flexibility & durability along with chemical resistance makes them highly functional for various applications in hospital and clinic applications. These factors, along with the stringent regulatory requirements from healthcare authorities like FDA, ensure that hospitals and clinics are adopting high-quality elastomer-based products. All these factors combined strong healthcare needs, adherence to regulatory requirements, and the drive for advanced, reliable medical devices ensure make hospitals & clinics account largest market share by industry in the medical elastomer market.

"Based on region, Asia Pacific accounts the second largest market for medical elastomer, in terms of value."

Asia Pacific accounts the second largest market for medical elastomers because of various factors such as economic development, rapid population growth, a good healthcare sector, and increasing demand for medical devices. The rise in investments for healthcare infrastructure in emerging economies like China and India is driving the demand for adoption high-quality medical elastomers into healthcare equipments such as medical tubing, implants, and diagnostic equipment. Large and aging population in the region have added up to this demand as prevalence of chronic diseases is rising among this population. Asia Pacific is, therefore, a growth product concerning medical facility organizations dedicated to better healthcare access, positioning it as a major player in the global medical elastomer market.

In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: Directors- 35%, Managers - 25%, and Others - 40%
  • By Region: North America - 22%, Europe - 22%, Asia Pacific - 45%, RoW - 11%

The key players in this market are BASF (Germany), Dow (US), Celanese Corporation (US), Eastman Chemical Company (US), Syensqo (Belgium), Mitsubishi Chemical Group Corporation (Japan), Kuraray Co., Ltd. (Japan), ExxonMobil (US), Momentive Performance Materials (US), Envalior (Germany) and Zeon Corporation (Japan).

Research Coverage

This report segments the medical elastomer market based on type, technology, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the medical elastomer market.

Key benefits of buying this report

This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the medical elastomer market, high-growth regions, and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing demand for medical devices, Technological advancements in healthcare and Prevalence of chronic diseases), restraints (High production costs), opportunities (Growing healthcare investment in emerging economies) and challenges (Stringent regulatory requirements).
  • Market Penetration: Comprehensive information on the medical elastomer market offered by top players in the global medical elastomer market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical elastomer market.
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for medical elastomer market across regions.
  • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global medical elastomer market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical elastomer market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNITS CONSIDERED
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 List of key primary interview participants
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of interviews with experts
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 GROWTH FORECAST
  • 2.4 DATA TRIANGULATION
  • 2.5 FACTOR ANALYSIS
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL ELASTOMERS MARKET
  • 4.2 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024 VS. 2029 (KILOTON)
  • 4.3 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024 VS. 2029 (KILOTON)
  • 4.4 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024 VS. 2029 (KILOTON)
  • 4.5 MEDICAL ELASTOMERS MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing demand for medical devices
      • 5.2.1.2 Technological advancements in healthcare
      • 5.2.1.3 Prevalence of chronic diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High production costs
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing healthcare investments in emerging economies
      • 5.2.3.2 Increasing use in minimally invasive devices
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent regulatory requirements
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT FROM NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.4.2 BUYING CRITERIA
  • 5.5 MACROECONOMIC OUTLOOK
    • 5.5.1 GDP TRENDS AND FORECASTS
  • 5.6 IMPACT OF AI/GENAI
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 CASE STUDY ANALYSIS
    • 5.9.1 KENT ELASTOMERS HELPED IN TRANSITIONING TO NON-LATEX MEDICAL COMPONENTS
    • 5.9.2 COOPER UNIVERSITY HOSPITAL BOOSTS POLYPHENYLENE ETHER RESILIENCE WITH DENTEC SAFETY COMFORT-AIRNXMD
    • 5.9.3 TECNOFLON FKM AS HIGH-PERFORMANCE ALTERNATIVE TO SILICONE IN ORTHOPEDIC APPLICATIONS
  • 5.10 REGULATORY LANDSCAPE
    • 5.10.1 ENVIRONMENTAL REGULATIONS
    • 5.10.2 NORTH AMERICA
    • 5.10.3 ASIA PACIFIC
    • 5.10.4 EUROPE
    • 5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGIES
      • 5.11.1.1 Extrusion technology
      • 5.11.1.2 Compression molding
    • 5.11.2 COMPLEMENTARY TECHNOLOGIES
      • 5.11.2.1 Co-extrusion technology
    • 5.11.3 ADJACENT TECHNOLOGIES
      • 5.11.3.1 Additive manufacturing technology
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.13 TRADE ANALYSIS
    • 5.13.1 IMPORT SCENARIO (HS CODE 391000)
    • 5.13.2 EXPORT SCENARIO (HS CODE 391000)
    • 5.13.3 IMPORT SCENARIO (HS CODE 400270)
    • 5.13.4 EXPORT SCENARIO (HS CODE 400270)
  • 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.15 PRICING ANALYSIS
    • 5.15.1 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY REGION
    • 5.15.2 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY APPLICATION
    • 5.15.3 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY END-USE INDUSTRY
  • 5.16 INVESTMENT AND FUNDING SCENARIO
  • 5.17 PATENT ANALYSIS
    • 5.17.1 INTRODUCTION
    • 5.17.2 LEGAL STATUS OF PATENTS
    • 5.17.3 JURISDICTION ANALYSIS
  • 5.18 LIST OF POTENTIAL CUSTOMERS

6 MEDICAL ELASTOMERS MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 EXTRUSION
  • 6.3 INJECTION MOLDING
  • 6.4 COMPRESSION MOLDING
  • 6.5 OTHER TECHNOLOGIES

7 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY

  • 7.1 INTRODUCTION
  • 7.2 HOSPITALS & CLINICS
    • 7.2.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 7.3 PHARMACEUTICAL
    • 7.3.1 CRUCIAL ROLE OF ELASTOMERS IN PACKAGING AND DRUG DELIVERY SYSTEMS TO PROPEL ADOPTION
  • 7.4 MEDICAL DEVICE MANUFACTURING
    • 7.4.1 RISING DEMAND FOR ADVANCED MEDICAL DEVICES TO SUPPORT MARKET GROWTH
  • 7.5 OTHER END-USE INDUSTRIES

8 MEDICAL ELASTOMERS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 MEDICAL TUBING
    • 8.2.1 HIGH CONSUMPTION IN ADVANCING MEDICAL TUBING SOLUTIONS TO DRIVE MARKET
  • 8.3 CATHETERS
    • 8.3.1 VITAL ROLE IN PRODUCTION OF CATHETERS TO PROPEL GROWTH
  • 8.4 GLOVES
    • 8.4.1 INCREASING NEED FOR PERSONAL PROTECTIVE EQUIPMENT TO INCREASE DEMAND
  • 8.5 SYRINGES
    • 8.5.1 PRE-FILLED SYRINGES
      • 8.5.1.1 Reduce risk of dosing errors-key factor driving adoption
    • 8.5.2 NON-PRE-FILLED SYRINGES
      • 8.5.2.1 Increasing incidence of chronic diseases to propel adoption
    • 8.5.3 VIALS
      • 8.5.3.1 Increasing need for safe and effective drug delivery systems to drive market
  • 8.6 MEDICAL & INFUSION BAGS
    • 8.6.1 RISE IN HOSPITAL-ACQUIRED INFECTIONS TO SUPPORT MARKET GROWTH
  • 8.7 IMPLANTS
    • 8.7.1 INCREASING PREVALENCE OF AGE-RELATED HEALTH CONDITIONS TO DRIVE MARKET
  • 8.8 OTHER APPLICATIONS

9 MEDICAL ELASTOMERS MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 THERMOSET ELASTOMERS
    • 9.2.1 SILICONE
      • 9.2.1.1 Efficient alternative to latex products in medical and pharmaceutical applications
      • 9.2.1.2 High temperature vulcanized
      • 9.2.1.3 Liquid silicone rubber
      • 9.2.1.4 Room temperature vulcanized
    • 9.2.2 ETHYLENE PROPYLENE DIENE MONOMER
      • 9.2.2.1 Suitable for various medical applications-key factor supporting market growth
    • 9.2.3 OTHER THERMOSET ELASTOMERS
  • 9.3 THERMOPLASTIC ELASTOMERS
    • 9.3.1 THERMOPLASTIC POLYURETHANE
      • 9.3.1.1 Provide efficiency in manufacturing complex designs using extrusion and molding techniques
    • 9.3.2 STYRENE BLOCK COPOLYMERS
      • 9.3.2.1 Biostability of SBC increases utility in medical applications-key factor driving market growth
    • 9.3.3 OTHER THERMOPLASTIC ELASTOMERS

10 MEDICAL ELASTOMERS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 Rising healthcare spending to drive market
    • 10.2.2 CANADA
      • 10.2.2.1 Expanding healthcare system to support market growth
    • 10.2.3 MEXICO
      • 10.2.3.1 Government initiatives and growth of healthcare sector to drive market
  • 10.3 ASIA PACIFIC
    • 10.3.1 CHINA
      • 10.3.1.1 Growing aging population to drive market
    • 10.3.2 JAPAN
      • 10.3.2.1 Increased focus on infection control and patient safety to propel market
    • 10.3.3 INDIA
      • 10.3.3.1 Increasing investments in healthcare sector to drive market
    • 10.3.4 SOUTH KOREA
      • 10.3.4.1 Rising demand for high quality medical devices to drive market
    • 10.3.5 INDONESIA
      • 10.3.5.1 Rising incidence of chronic diseases to drive market
    • 10.3.6 REST OF ASIA PACIFIC
  • 10.4 EUROPE
    • 10.4.1 GERMANY
      • 10.4.1.1 Increased investments in R&D to drive market
    • 10.4.2 UK
      • 10.4.2.1 Rising geriatric population to support market growth
    • 10.4.3 FRANCE
      • 10.4.3.1 Presence of significant medical device manufacturers to propel market
    • 10.4.4 ITALY
      • 10.4.4.1 Rising demand for medical devices from public hospitals to increase demand
    • 10.4.5 SPAIN
      • 10.4.5.1 Increasing investments in healthcare infrastructure to propel market
    • 10.4.6 REST OF EUROPE
  • 10.5 MIDDLE EAST & AFRICA
    • 10.5.1 GCC COUNTRIES
      • 10.5.1.1 Saudi Arabia
        • 10.5.1.1.1 Need for advanced medical technologies to drive market
      • 10.5.1.2 Rest of GCC countries
    • 10.5.2 SOUTH AFRICA
      • 10.5.2.1 Outbreak of contagious diseases to drive market
    • 10.5.3 REST OF MIDDLE EAST & AFRICA
  • 10.6 SOUTH AMERICA
    • 10.6.1 BRAZIL
      • 10.6.1.1 Largest market for medical elastomers in South America
    • 10.6.2 ARGENTINA
      • 10.6.2.1 Growing demand for medical devices to drive market
    • 10.6.3 REST OF SOUTH AMERICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2019-2024
  • 11.3 REVENUE ANALYSIS, 2021-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
    • 11.4.1 NORTH AMERICA: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
    • 11.4.2 EUROPE: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
    • 11.4.3 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
    • 11.4.4 DOW
    • 11.4.5 EXXON MOBIL CORPORATION
    • 11.4.6 CELANESE CORPORATION
    • 11.4.7 BASF
    • 11.4.8 WACKER CHEMIE AG
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON
    • 11.6.1 MEDICAL ELASTOMERS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
    • 11.6.2 ELASTOLLAN
    • 11.6.3 ENGAGE 8480K HEALTH+
    • 11.6.4 HYTREL
    • 11.6.5 ECDEL
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.7.5.1 Overall company footprint
      • 11.7.5.2 Region footprint
      • 11.7.5.3 Technology footprint
      • 11.7.5.4 Type Footprint
      • 11.7.5.5 Application footprint
      • 11.7.5.6 Industry footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 11.8.5.1 Detailed list of startups/SMEs
      • 11.8.5.2 Competitive benchmarking of startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS
    • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 DOW
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Other developments
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 EXXON MOBIL CORPORATION
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 MnM view
        • 12.1.2.3.1 Key strengths
        • 12.1.2.3.2 Strategic choices
        • 12.1.2.3.3 Weaknesses and competitive threats
    • 12.1.3 CELANESE CORPORATION
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 BASF
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 WACKER CHEMIE AG
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
        • 12.1.5.3.2 Expansions
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses and competitive threats
    • 12.1.6 EASTMAN CHEMICAL COMPANY
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 MnM view
        • 12.1.6.3.1 Key strengths
        • 12.1.6.3.2 Strategic choices
        • 12.1.6.3.3 Weaknesses and competitive threats
    • 12.1.7 SYENSQO
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Other developments
      • 12.1.7.4 MnM view
        • 12.1.7.4.1 Key strengths
        • 12.1.7.4.2 Strategic choices
        • 12.1.7.4.3 Weaknesses and competitive threats
    • 12.1.8 KURARAY CO., LTD
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 MnM view
        • 12.1.8.3.1 Key strengths
        • 12.1.8.3.2 Strategic choices
        • 12.1.8.3.3 Weaknesses and competitive threats
    • 12.1.9 MITSUBISHI CHEMICAL GROUP CORPORATION
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Other developments
        • 12.1.9.3.2 Deals
      • 12.1.9.4 MnM view
    • 12.1.10 MOMENTIVE PERFORMANCE MATERIALS
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
      • 12.1.10.3 MnM view
    • 12.1.11 ENVALIOR
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 ZEON CORPORATION
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
    • 12.1.13 THE LUBRIZOL CORPORATION
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
      • 12.1.13.3 MnM view
  • 12.2 OTHER PLAYERS
    • 12.2.1 KRATON CORPORATION
    • 12.2.2 FOSTER CORPORATION
    • 12.2.3 BIOMERICS
    • 12.2.4 RTP COMPANY
    • 12.2.5 ROMAR ENGINEERING
    • 12.2.6 THE RUBBER GROUP
    • 12.2.7 KENT ELASTOMER PRODUCTS
    • 12.2.8 RAUMEDIC AG
    • 12.2.9 THE HYGENIC COMPANY, LLC
    • 12.2.10 HEXAPOL AB
    • 12.2.11 TEKNI-PLEX, INC
    • 12.2.12 TRINSEO
    • 12.2.13 TRELLEBORG AB
    • 12.2.14 SAINT-GOBAIN

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제